Immunohistochemical staining showed that the PELI2 expression in oePELI2 group tumors was significantly higher than Vector group tumors, and Ki-67 staining confirmed that oePELI2 could reduce proliferation of tumor cells in vivo (Fig. 4H). The gene discussed is PELI2; the disease is neoplasm.